Filing metadata

Accession number
0001140361-24-033600
Form type
Form 4
Filer
Acrivon Therapeutics, Inc.
CIK
CIK 1781174
Filed
Jul 19, 2024
Reporting period
Jul 17, 2024
Description
Insider transaction

Explore SEC Filings Hub